Hudson Capital Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,700
| Closed | -$207K | – | 67 |
|
|
2024
Q4 | $207K | Hold |
1,700
| – | – | 0.06% | 66 |
|
|
2024
Q3 | $212K | Hold |
1,700
| – | – | 0.07% | 65 |
|
|
2024
Q2 | $269K | Hold |
1,700
| – | – | 0.09% | 56 |
|
|
2024
Q1 | $220K | Buy |
+1,700
| New | +$220K | 0.08% | 61 |
|
|
2023
Q4 | – | Sell |
-1,700
| Closed | -$206K | – | 71 |
|
|
2023
Q3 | $206K | Buy |
+1,700
| New | +$206K | 0.08% | 61 |
|
|
2023
Q2 | – | Sell |
-1,500
| Closed | -$207K | – | 69 |
|
|
2023
Q1 | $207K | Buy |
+1,500
| New | +$207K | 0.08% | 61 |
|
|
2021
Q1 | – | Sell |
-1,500
| Closed | -$256K | – | 69 |
|
|
2020
Q4 | $256K | Hold |
1,500
| – | – | 0.11% | 57 |
|
|
2020
Q3 | $211K | Hold |
1,500
| – | – | 0.1% | 60 |
|
|
2020
Q2 | $241K | Buy |
+1,500
| New | +$241K | 0.13% | 65 |
|